InvestorsObserver
×
News Home

BioCardia Inc (BCDA) Stock: Do Analysts Think You Should Buy?

Tuesday, November 14, 2023 09:36 AM | InvestorsObserver Analysts

Mentioned in this article

BioCardia Inc (BCDA) Stock: Do Analysts Think You Should Buy?

Analysts who follow BioCardia Inc (BCDA) on average expect it to increase 1150.00% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns BioCardia Inc an Analyst Ranking of 25, which means it ranks higher than 25 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.7
Wall Street analysts are rating BCDA a Buy today. Find out what this means to you and get the rest of the rankings on BCDA!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With BioCardia Inc Stock Today?

BioCardia Inc (BCDA) stock is unmoved 0% while the S&P 500 is higher by 1.44% as of 4:00 PM on Monday, Nov 13. BCDA is unmoved $0.00 from the previous closing price of $0.40 on volume of 39,170,298 shares. Over the past year the S&P 500 has gained 13.09% while BCDA has fallen -78.61%. BCDA lost -$0.63 per share the over the last 12 months. Click Here to get the full Stock Report for BioCardia Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App